Skip to content

Author

Hani Jneid

We have 5 of 37 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

A Propensity-Matched Analysis of Pre Versus Concomitant Percutaneous Coronary Intervention in Patients Undergoing Transcatheter Aortic Valve Replacement With Frailty-Related High-Risk Features.

BACKGROUND Percutaneous coronary intervention (PCI) is frequently performed in patients undergoing transcatheter aortic valve replacement (TAVR); however, the optimal timing of PCI remains uncertain, particularly in patients with frailty-related high-risk features. Evidence comparing pre-TAVR versus concomitant PCI str...

Avery Love, Duc-Hieu Bui, Shahman Shahab et al. · 0 citations
Sep 2026

Safety, Efficacy, and Effectiveness of Pulsed Field Ablation with Farapulse™ to Treat Atrial Fibrillation: A Prospective Single-center Study

Pulsed field ablation (PFA) using the Farapulse™ system (Boston Scientific, Marlborough, MA, USA) is a novel, non-thermal ablation technology developed to treat atrial fibrillation (AF) with improved safety and procedural efficiency. We present prospective single-center data on the safety, efficacy, and effectiveness o...

Dean Sabayon, Deaa Abu Jazar, K. Alabdallah et al. · 0 citations
Open access Oct 2026

Cardiovascular and Kidney Outcomes of Tirzepatide versus Semaglutide in Stage 2 Cardiovascular-Kidney-Metabolic Syndrome: A Propensity Score-matched Cohort Study

Cardiovascular-kidney-metabolic (CKM) syndrome describes the overlapping burden of metabolic dysfunction, chronic kidney disease, and cardiovascular disease. Tirzepatide and semaglutide are both recommended for patients with type 2 diabetes and obesity, yet no randomized trial has directly compared their effect on...

A. Qadeer, M. Khalid, D. Leblanc et al. · 0 citations
Review Open access Sep 2026

The PREVENT Equations Evidence Appraisal of Validation and Clinical Implications.

The American Heart Association's PREVENT equations offer a contemporary, race-free alternative to the Pooled Cohort Equations (PCE), incorporating kidney function to estimate 10- and 30-year risks of atherosclerotic cardiovascular disease (ASCVD), heart failure, and total CVD. PREVENT-ASCVD is now recommended for prima...

I. Mortada, Ebrahim Adel Elkolaly, Aaron W. Lee et al. · 0 citations
Jul 2026

Secondary Atrial Fibrillation in Critically Ill Sepsis Patients: Evaluating the Role of Early Oral Anticoagulants in a Retrospective Multi-Center Study.

In sepsis-associated NOAF, early OAC initiation was associated with reduced short-term mortality and ischemic stroke without excess bleeding or thromboembolic risk and warrant cautious interpretation given the observational design.

A. Qadeer, Michele Fouad, Doaa Bayomi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.